Myostatin and muscle atrophy during chronic kidney disease

Chronic kidney disease (CKD) patients often exhibit a low muscle mass and strength, leading to physical impairment and an increased mortality. Two major signalling pathways control protein synthesis, the insulin-like growth factor-1/Akt (IGF-1/Akt) pathway, acting as a positive regulator, and the my...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Nephrology, dialysis, transplantation Jg. 36; H. 11; S. 1986
Hauptverfasser:	Bataille, Stanislas, Chauveau, Philippe, Fouque, Denis, Aparicio, Michel, Koppe, Laetitia
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	England 09.11.2021
Schlagworte:	Humans Muscle, Skeletal Muscular Atrophy - etiology Myostatin Renal Dialysis Renal Insufficiency, Chronic - therapy Uremic Toxins wasting chronic kidney disease myostatin sarcopenia
ISSN:	1460-2385, 1460-2385
Online-Zugang:	Weitere Angaben
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!